HT-101 monotherapy with 2 injections achieves surface antigen (HBsAg) seroconversion in 48 weeks! Hepa Thera HT-101 clinical trial makes breakthrough progress!-Suzhou Xingyao Kunze Biopharmaceutical Co., Ltd.